Stock CLOV CLOVER HEALTH INVESTMENTS, CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Clover Health Investments, Corp.

Equities

CLOV

US18914F1030

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-31 pm EDT 		5-day change 1st Jan Change
1.1 USD -3.51% Intraday chart for Clover Health Investments, Corp. +10.00% +15.53%
May. 29 Clover Health Investments to Offer AI Tool 'Clover Assistant' Outside Medicare Plan MT
May. 29 Clover Health Investments, Corp. Announces Counterpart Health, A New SaaS and Tech Enabled Services Solution to Bring the Power of CA Technology to All Medicare Advantage Payors and Providers CI

Summary

  • On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.

Strengths

  • The stock, which is currently worth 2024 to 0.35 times its sales, is clearly overvalued in comparison with peers.
  • Over the past twelve months, analysts' opinions have been strongly revised upwards.

Weaknesses

  • As estimated by analysts, this group is among those businesses with the lowest growth prospects.
  • As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
  • The company has insufficient levels of profitability.
  • For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
  • The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
  • For the past year, analysts have significantly revised downwards their profit estimates.
  • For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
  • The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.

Ratings chart - Surperformance

Sector: Managed Healthcare

1st Jan change Capi. Investor Rating ESG Refinitiv
CLOVER HEALTH INVESTMENTS, CORP. Stock Clover Health Investments, Corp.
+15.53% 546M -
UNITEDHEALTH GROUP INC. Stock UnitedHealth Group Inc.
-5.91% 456B
B-
ELEVANCE HEALTH, INC. Stock Elevance Health, Inc.
+14.19% 125B
A-
CIGNA Stock Cigna
+15.08% 97.9B
B-
HUMANA INC. Stock Humana Inc.
-21.78% 43.15B
A-
CENTENE CORPORATION Stock Centene Corporation
-3.53% 38.2B
B-
MOLINA HEALTHCARE, INC. Stock Molina Healthcare, Inc.
-12.93% 18.43B
B-
PROGYNY, INC. Stock Progyny, Inc.
-27.51% 2.57B
C+
ALIGNMENT HEALTHCARE, INC. Stock Alignment Healthcare, Inc.
-8.59% 1.5B
B-
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
-
EV / Sales
Price to Book
-
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. CLOV Stock
  4. Ratings Clover Health Investments, Corp.